Cannabis Stock Pure play marijuana stocks are scarce. Most companies in the marijuana industry trade over the counter (OTC), where solid information regarding operations and financials is difficult to retrieve. Exceptions extend to issues such as GW Pharmaceuticals plc (NASDAQ: GWPH), a British biopharmaceutical company that developed two cannabis-based drugs licensed for use outside the United States. Sativex is used to treat muscular contractions in multiple sclerosis patients, and Epidiolex targets epileptic seizures in children. Both drugs have entered Phase 3 clinical stage trials in the United States. GWPH has a $2 billion market cap and had returned 23% year to date (YTD) as of Aug. 15, 2016.
Political and legal obstacles remain the highest hurdles for the marijuana industry in 2016. Four states, Oregon, Washington, Alaska and Colorado, have legalized recreational marijuana, and 25 states plus the District of Columbia have approved cannabis for medicinal purposes. The plant is categorized at the federal level as a Schedule 1 drug, possessing the highest risk for psychological and physical dependence, and more curiously, having no acceptable medical use.
A February 2016 survey conducted by the Associated Press-NORC Center for Public Affairs Research revealed that 61% of Americans support marijuana legalization, up from 58% in October 2015. Four additional states, Arizona, California, Massachusetts and Nevada, vote on recreational legalization in November 2016. The Obama presidency has seen a 17% increase in legal cannabis supporters since 2008, and the next administration likely faces mounting pressure to initiate further federal reform.
U.S. cannabis issues face considerable headwinds, as the drug is still illegal at the national level. As such, marijuana growers, processors and dispensaries are subject to considerable taxation by state and federal agencies.
Among the 83 publicly traded stocks tracked by MarijuanaStocks.com, only three traded for more than $5 per share as of Aug. 3, 2016, with the vast majority positioned below $1. Investors willing to take a flyer on an upstart cannabis purveyor may bear the risk, but most discerning buyers avoid these issues.
Emblem To Disrupt $60 Billion Opiod Market With Cannabis Based Sustained Release Formulation Symbol: EMC Emblem Corp. (TSXV:EMC) (EMC.WT) (“Emblem” or the “Company”) announced today that it has entered into a Collaboration and Licensing Agreement (the “Agreement”) with Canntab Therapeutics Limited (“Canntab”) of Toronto. Canntab has developed a patent-pending oral sustained release formulation for cannabinoids
Future Farm Bringing Augmented Reality To The Cannabis Industry Under Exclusive License To Patented IP September 28, 2017 – Vancouver, British Columbia – Future Farm Technologies Inc. (the “Company” or “Future Farm”) (CSE: FFT) (OTCQB: FFRMF) is pleased to announce that it has signed a license agreement with AR E1, LLC (“ARE1”) wherein the
WeedMD Signs Exclusive Cannabis Supply Agreements with Three Long-Term Care and Retirement Home Providers WeedMD Inc. (TSX-V:WMD) (“WeedMD” or the “Company”), a federally licensed producer and distributor of medical cannabis, is pleased to announce that it has signed agreements to supply medicinal cannabis products on an exclusive basis with three long-term care (“LTC”) and
American Cannabis Company, Inc. Signs Exclusive Distribution Agreement with Earth Alive American Cannabis Company, Inc. (OTCQB : AMMJ ) (“ACC”), a full-service business-to-business consulting solutions provider, and seller of ancillary products to the cannabis industry, today announced it has signed an exclusive distribution agreement with Earth Alive, a leading Canadian clean-tech company that develops and manufactures state-of-the-art microbial
Terra Tech Corp. (TRTC) Signs Letter of Intent to Acquire Cannabis Cultivation and Production Facilities in Nevada Terra Tech Corp. (TRTC) (“Terra Tech” or the “Company”), a vertically integrated, cannabis-focused agriculture company, announced today that it has signed a non-binding letter of intent to acquire 50% of NuLeaf Sparks Cultivation LLC and NuLeaf Reno Production LLC. The